0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hydromorphone Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-26V8157
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Hydromorphone Market Insights Forecast to 2028
BUY CHAPTERS

Global Hydromorphone Market Research Report 2025

Code: QYRE-Auto-26V8157
Report
July 2025
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hydromorphone Market Size

The global market for Hydromorphone was valued at US$ 1143 million in the year 2024 and is projected to reach a revised size of US$ 1560 million by 2031, growing at a CAGR of 4.6% during the forecast period.

Hydromorphone Market

Hydromorphone Market

Hydromorphone, also known as dihydromorphinone, and sold under the brand name Dilaudid among others, is an opioid used to treat moderate to severe pain. Typically, long-term use is only recommended for pain due to cancer
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hydromorphone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hydromorphone.
The Hydromorphone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hydromorphone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hydromorphone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Hydromorphone Market Report

Report Metric Details
Report Name Hydromorphone Market
Accounted market size in year US$ 1143 million
Forecasted market size in 2031 US$ 1560 million
CAGR 4.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Oral
  • Injection
Segment by Application
  • Hospital
  • Drug Store
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Purdue Pharma, Akorn, Barr Pharmaceuticals, Pfizer, Watson Laboratories, Mallinckrodt, Teva Pharmaceuticals, KV Pharmaceutical, Lannett, Apotex, Fresenius, Johnson and Johnson, Mundipharma, Novartis, Stada Arzneimittel, Mylan
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Hydromorphone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Hydromorphone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Hydromorphone Market growing?

Ans: The Hydromorphone Market witnessing a CAGR of 4.6% during the forecast period 2025-2031.

What is the Hydromorphone Market size in 2031?

Ans: The Hydromorphone Market size in 2031 will be US$ 1560 million.

Who are the main players in the Hydromorphone Market report?

Ans: The main players in the Hydromorphone Market are Purdue Pharma, Akorn, Barr Pharmaceuticals, Pfizer, Watson Laboratories, Mallinckrodt, Teva Pharmaceuticals, KV Pharmaceutical, Lannett, Apotex, Fresenius, Johnson and Johnson, Mundipharma, Novartis, Stada Arzneimittel, Mylan

What are the Application segmentation covered in the Hydromorphone Market report?

Ans: The Applications covered in the Hydromorphone Market report are Hospital, Drug Store

What are the Type segmentation covered in the Hydromorphone Market report?

Ans: The Types covered in the Hydromorphone Market report are Oral, Injection

Recommended Reports

Pain Management

Hydrochloride APIs

Pain Relief Solutions

1 Hydromorphone Market Overview
1.1 Product Definition
1.2 Hydromorphone by Type
1.2.1 Global Hydromorphone Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral
1.2.3 Injection
1.3 Hydromorphone by Application
1.3.1 Global Hydromorphone Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Hydromorphone Market Size Estimates and Forecasts
1.4.1 Global Hydromorphone Revenue 2020-2031
1.4.2 Global Hydromorphone Sales 2020-2031
1.4.3 Global Hydromorphone Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Hydromorphone Market Competition by Manufacturers
2.1 Global Hydromorphone Sales Market Share by Manufacturers (2020-2025)
2.2 Global Hydromorphone Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Hydromorphone Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Hydromorphone, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hydromorphone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hydromorphone, Product Type & Application
2.7 Global Key Manufacturers of Hydromorphone, Date of Enter into This Industry
2.8 Global Hydromorphone Market Competitive Situation and Trends
2.8.1 Global Hydromorphone Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Hydromorphone Players Market Share by Revenue
2.8.3 Global Hydromorphone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hydromorphone Market Scenario by Region
3.1 Global Hydromorphone Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Hydromorphone Sales by Region: 2020-2031
3.2.1 Global Hydromorphone Sales by Region: 2020-2025
3.2.2 Global Hydromorphone Sales by Region: 2026-2031
3.3 Global Hydromorphone Revenue by Region: 2020-2031
3.3.1 Global Hydromorphone Revenue by Region: 2020-2025
3.3.2 Global Hydromorphone Revenue by Region: 2026-2031
3.4 North America Hydromorphone Market Facts & Figures by Country
3.4.1 North America Hydromorphone Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Hydromorphone Sales by Country (2020-2031)
3.4.3 North America Hydromorphone Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hydromorphone Market Facts & Figures by Country
3.5.1 Europe Hydromorphone Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Hydromorphone Sales by Country (2020-2031)
3.5.3 Europe Hydromorphone Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hydromorphone Market Facts & Figures by Region
3.6.1 Asia Pacific Hydromorphone Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Hydromorphone Sales by Region (2020-2031)
3.6.3 Asia Pacific Hydromorphone Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hydromorphone Market Facts & Figures by Country
3.7.1 Latin America Hydromorphone Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Hydromorphone Sales by Country (2020-2031)
3.7.3 Latin America Hydromorphone Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hydromorphone Market Facts & Figures by Country
3.8.1 Middle East and Africa Hydromorphone Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Hydromorphone Sales by Country (2020-2031)
3.8.3 Middle East and Africa Hydromorphone Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hydromorphone Sales by Type (2020-2031)
4.1.1 Global Hydromorphone Sales by Type (2020-2025)
4.1.2 Global Hydromorphone Sales by Type (2026-2031)
4.1.3 Global Hydromorphone Sales Market Share by Type (2020-2031)
4.2 Global Hydromorphone Revenue by Type (2020-2031)
4.2.1 Global Hydromorphone Revenue by Type (2020-2025)
4.2.2 Global Hydromorphone Revenue by Type (2026-2031)
4.2.3 Global Hydromorphone Revenue Market Share by Type (2020-2031)
4.3 Global Hydromorphone Price by Type (2020-2031)
5 Segment by Application
5.1 Global Hydromorphone Sales by Application (2020-2031)
5.1.1 Global Hydromorphone Sales by Application (2020-2025)
5.1.2 Global Hydromorphone Sales by Application (2026-2031)
5.1.3 Global Hydromorphone Sales Market Share by Application (2020-2031)
5.2 Global Hydromorphone Revenue by Application (2020-2031)
5.2.1 Global Hydromorphone Revenue by Application (2020-2025)
5.2.2 Global Hydromorphone Revenue by Application (2026-2031)
5.2.3 Global Hydromorphone Revenue Market Share by Application (2020-2031)
5.3 Global Hydromorphone Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Purdue Pharma
6.1.1 Purdue Pharma Company Information
6.1.2 Purdue Pharma Description and Business Overview
6.1.3 Purdue Pharma Hydromorphone Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Purdue Pharma Hydromorphone Product Portfolio
6.1.5 Purdue Pharma Recent Developments/Updates
6.2 Akorn
6.2.1 Akorn Company Information
6.2.2 Akorn Description and Business Overview
6.2.3 Akorn Hydromorphone Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Akorn Hydromorphone Product Portfolio
6.2.5 Akorn Recent Developments/Updates
6.3 Barr Pharmaceuticals
6.3.1 Barr Pharmaceuticals Company Information
6.3.2 Barr Pharmaceuticals Description and Business Overview
6.3.3 Barr Pharmaceuticals Hydromorphone Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Barr Pharmaceuticals Hydromorphone Product Portfolio
6.3.5 Barr Pharmaceuticals Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Hydromorphone Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Hydromorphone Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Watson Laboratories
6.5.1 Watson Laboratories Company Information
6.5.2 Watson Laboratories Description and Business Overview
6.5.3 Watson Laboratories Hydromorphone Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Watson Laboratories Hydromorphone Product Portfolio
6.5.5 Watson Laboratories Recent Developments/Updates
6.6 Mallinckrodt
6.6.1 Mallinckrodt Company Information
6.6.2 Mallinckrodt Description and Business Overview
6.6.3 Mallinckrodt Hydromorphone Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Mallinckrodt Hydromorphone Product Portfolio
6.6.5 Mallinckrodt Recent Developments/Updates
6.7 Teva Pharmaceuticals
6.7.1 Teva Pharmaceuticals Company Information
6.7.2 Teva Pharmaceuticals Description and Business Overview
6.7.3 Teva Pharmaceuticals Hydromorphone Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Teva Pharmaceuticals Hydromorphone Product Portfolio
6.7.5 Teva Pharmaceuticals Recent Developments/Updates
6.8 KV Pharmaceutical
6.8.1 KV Pharmaceutical Company Information
6.8.2 KV Pharmaceutical Description and Business Overview
6.8.3 KV Pharmaceutical Hydromorphone Sales, Revenue and Gross Margin (2020-2025)
6.8.4 KV Pharmaceutical Hydromorphone Product Portfolio
6.8.5 KV Pharmaceutical Recent Developments/Updates
6.9 Lannett
6.9.1 Lannett Company Information
6.9.2 Lannett Description and Business Overview
6.9.3 Lannett Hydromorphone Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Lannett Hydromorphone Product Portfolio
6.9.5 Lannett Recent Developments/Updates
6.10 Apotex
6.10.1 Apotex Company Information
6.10.2 Apotex Description and Business Overview
6.10.3 Apotex Hydromorphone Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Apotex Hydromorphone Product Portfolio
6.10.5 Apotex Recent Developments/Updates
6.11 Fresenius
6.11.1 Fresenius Company Information
6.11.2 Fresenius Description and Business Overview
6.11.3 Fresenius Hydromorphone Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Fresenius Hydromorphone Product Portfolio
6.11.5 Fresenius Recent Developments/Updates
6.12 Johnson and Johnson
6.12.1 Johnson and Johnson Company Information
6.12.2 Johnson and Johnson Description and Business Overview
6.12.3 Johnson and Johnson Hydromorphone Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Johnson and Johnson Hydromorphone Product Portfolio
6.12.5 Johnson and Johnson Recent Developments/Updates
6.13 Mundipharma
6.13.1 Mundipharma Company Information
6.13.2 Mundipharma Description and Business Overview
6.13.3 Mundipharma Hydromorphone Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Mundipharma Hydromorphone Product Portfolio
6.13.5 Mundipharma Recent Developments/Updates
6.14 Novartis
6.14.1 Novartis Company Information
6.14.2 Novartis Description and Business Overview
6.14.3 Novartis Hydromorphone Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Novartis Hydromorphone Product Portfolio
6.14.5 Novartis Recent Developments/Updates
6.15 Stada Arzneimittel
6.15.1 Stada Arzneimittel Company Information
6.15.2 Stada Arzneimittel Description and Business Overview
6.15.3 Stada Arzneimittel Hydromorphone Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Stada Arzneimittel Hydromorphone Product Portfolio
6.15.5 Stada Arzneimittel Recent Developments/Updates
6.16 Mylan
6.16.1 Mylan Company Information
6.16.2 Mylan Description and Business Overview
6.16.3 Mylan Hydromorphone Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Mylan Hydromorphone Product Portfolio
6.16.5 Mylan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hydromorphone Industry Chain Analysis
7.2 Hydromorphone Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hydromorphone Production Mode & Process Analysis
7.4 Hydromorphone Sales and Marketing
7.4.1 Hydromorphone Sales Channels
7.4.2 Hydromorphone Distributors
7.5 Hydromorphone Customer Analysis
8 Hydromorphone Market Dynamics
8.1 Hydromorphone Industry Trends
8.2 Hydromorphone Market Drivers
8.3 Hydromorphone Market Challenges
8.4 Hydromorphone Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Hydromorphone Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Hydromorphone Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Hydromorphone Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Hydromorphone Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Hydromorphone Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Hydromorphone Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Hydromorphone Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Hydromorphone Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Hydromorphone, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Hydromorphone, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Hydromorphone, Product Type & Application
 Table 12. Global Key Manufacturers of Hydromorphone, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Hydromorphone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hydromorphone as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Hydromorphone Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Hydromorphone Sales by Region (2020-2025) & (K Units)
 Table 18. Global Hydromorphone Sales Market Share by Region (2020-2025)
 Table 19. Global Hydromorphone Sales by Region (2026-2031) & (K Units)
 Table 20. Global Hydromorphone Sales Market Share by Region (2026-2031)
 Table 21. Global Hydromorphone Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Hydromorphone Revenue Market Share by Region (2020-2025)
 Table 23. Global Hydromorphone Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Hydromorphone Revenue Market Share by Region (2026-2031)
 Table 25. North America Hydromorphone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Hydromorphone Sales by Country (2020-2025) & (K Units)
 Table 27. North America Hydromorphone Sales by Country (2026-2031) & (K Units)
 Table 28. North America Hydromorphone Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Hydromorphone Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Hydromorphone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Hydromorphone Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Hydromorphone Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Hydromorphone Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Hydromorphone Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Hydromorphone Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Hydromorphone Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Hydromorphone Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Hydromorphone Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Hydromorphone Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Hydromorphone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Hydromorphone Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Hydromorphone Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Hydromorphone Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Hydromorphone Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Hydromorphone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Hydromorphone Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Hydromorphone Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Hydromorphone Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Hydromorphone Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Hydromorphone Sales (K Units) by Type (2020-2025)
 Table 51. Global Hydromorphone Sales (K Units) by Type (2026-2031)
 Table 52. Global Hydromorphone Sales Market Share by Type (2020-2025)
 Table 53. Global Hydromorphone Sales Market Share by Type (2026-2031)
 Table 54. Global Hydromorphone Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Hydromorphone Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Hydromorphone Revenue Market Share by Type (2020-2025)
 Table 57. Global Hydromorphone Revenue Market Share by Type (2026-2031)
 Table 58. Global Hydromorphone Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Hydromorphone Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Hydromorphone Sales (K Units) by Application (2020-2025)
 Table 61. Global Hydromorphone Sales (K Units) by Application (2026-2031)
 Table 62. Global Hydromorphone Sales Market Share by Application (2020-2025)
 Table 63. Global Hydromorphone Sales Market Share by Application (2026-2031)
 Table 64. Global Hydromorphone Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Hydromorphone Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Hydromorphone Revenue Market Share by Application (2020-2025)
 Table 67. Global Hydromorphone Revenue Market Share by Application (2026-2031)
 Table 68. Global Hydromorphone Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Hydromorphone Price (US$/Unit) by Application (2026-2031)
 Table 70. Purdue Pharma Company Information
 Table 71. Purdue Pharma Description and Business Overview
 Table 72. Purdue Pharma Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Purdue Pharma Hydromorphone Product
 Table 74. Purdue Pharma Recent Developments/Updates
 Table 75. Akorn Company Information
 Table 76. Akorn Description and Business Overview
 Table 77. Akorn Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Akorn Hydromorphone Product
 Table 79. Akorn Recent Developments/Updates
 Table 80. Barr Pharmaceuticals Company Information
 Table 81. Barr Pharmaceuticals Description and Business Overview
 Table 82. Barr Pharmaceuticals Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Barr Pharmaceuticals Hydromorphone Product
 Table 84. Barr Pharmaceuticals Recent Developments/Updates
 Table 85. Pfizer Company Information
 Table 86. Pfizer Description and Business Overview
 Table 87. Pfizer Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Pfizer Hydromorphone Product
 Table 89. Pfizer Recent Developments/Updates
 Table 90. Watson Laboratories Company Information
 Table 91. Watson Laboratories Description and Business Overview
 Table 92. Watson Laboratories Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Watson Laboratories Hydromorphone Product
 Table 94. Watson Laboratories Recent Developments/Updates
 Table 95. Mallinckrodt Company Information
 Table 96. Mallinckrodt Description and Business Overview
 Table 97. Mallinckrodt Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Mallinckrodt Hydromorphone Product
 Table 99. Mallinckrodt Recent Developments/Updates
 Table 100. Teva Pharmaceuticals Company Information
 Table 101. Teva Pharmaceuticals Description and Business Overview
 Table 102. Teva Pharmaceuticals Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Teva Pharmaceuticals Hydromorphone Product
 Table 104. Teva Pharmaceuticals Recent Developments/Updates
 Table 105. KV Pharmaceutical Company Information
 Table 106. KV Pharmaceutical Description and Business Overview
 Table 107. KV Pharmaceutical Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. KV Pharmaceutical Hydromorphone Product
 Table 109. KV Pharmaceutical Recent Developments/Updates
 Table 110. Lannett Company Information
 Table 111. Lannett Description and Business Overview
 Table 112. Lannett Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Lannett Hydromorphone Product
 Table 114. Lannett Recent Developments/Updates
 Table 115. Apotex Company Information
 Table 116. Apotex Description and Business Overview
 Table 117. Apotex Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Apotex Hydromorphone Product
 Table 119. Apotex Recent Developments/Updates
 Table 120. Fresenius Company Information
 Table 121. Fresenius Description and Business Overview
 Table 122. Fresenius Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Fresenius Hydromorphone Product
 Table 124. Fresenius Recent Developments/Updates
 Table 125. Johnson and Johnson Company Information
 Table 126. Johnson and Johnson Description and Business Overview
 Table 127. Johnson and Johnson Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Johnson and Johnson Hydromorphone Product
 Table 129. Johnson and Johnson Recent Developments/Updates
 Table 130. Mundipharma Company Information
 Table 131. Mundipharma Description and Business Overview
 Table 132. Mundipharma Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Mundipharma Hydromorphone Product
 Table 134. Mundipharma Recent Developments/Updates
 Table 135. Novartis Company Information
 Table 136. Novartis Description and Business Overview
 Table 137. Novartis Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Novartis Hydromorphone Product
 Table 139. Novartis Recent Developments/Updates
 Table 140. Stada Arzneimittel Company Information
 Table 141. Stada Arzneimittel Description and Business Overview
 Table 142. Stada Arzneimittel Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Stada Arzneimittel Hydromorphone Product
 Table 144. Stada Arzneimittel Recent Developments/Updates
 Table 145. Mylan Company Information
 Table 146. Mylan Description and Business Overview
 Table 147. Mylan Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Mylan Hydromorphone Product
 Table 149. Mylan Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Hydromorphone Distributors List
 Table 153. Hydromorphone Customers List
 Table 154. Hydromorphone Market Trends
 Table 155. Hydromorphone Market Drivers
 Table 156. Hydromorphone Market Challenges
 Table 157. Hydromorphone Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Hydromorphone
 Figure 2. Global Hydromorphone Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Hydromorphone Market Share by Type: 2024 & 2031
 Figure 4. Oral Product Picture
 Figure 5. Injection Product Picture
 Figure 6. Global Hydromorphone Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Hydromorphone Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Drug Store
 Figure 10. Global Hydromorphone Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Hydromorphone Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Hydromorphone Sales (2020-2031) & (K Units)
 Figure 13. Global Hydromorphone Average Price (US$/Unit) & (2020-2031)
 Figure 14. Hydromorphone Report Years Considered
 Figure 15. Hydromorphone Sales Share by Manufacturers in 2024
 Figure 16. Global Hydromorphone Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Hydromorphone Players: Market Share by Revenue in Hydromorphone in 2024
 Figure 18. Hydromorphone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Hydromorphone Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Hydromorphone Sales Market Share by Country (2020-2031)
 Figure 21. North America Hydromorphone Revenue Market Share by Country (2020-2031)
 Figure 22. United States Hydromorphone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Hydromorphone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Hydromorphone Sales Market Share by Country (2020-2031)
 Figure 25. Europe Hydromorphone Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Hydromorphone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Hydromorphone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Hydromorphone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Hydromorphone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Hydromorphone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Hydromorphone Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Hydromorphone Revenue Market Share by Region (2020-2031)
 Figure 33. China Hydromorphone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Hydromorphone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Hydromorphone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Hydromorphone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Hydromorphone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Hydromorphone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Hydromorphone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Hydromorphone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Hydromorphone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Hydromorphone Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Hydromorphone Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Hydromorphone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Hydromorphone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Hydromorphone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Hydromorphone Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Hydromorphone Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Hydromorphone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Hydromorphone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Hydromorphone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Hydromorphone by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Hydromorphone by Type (2020-2031)
 Figure 54. Global Hydromorphone Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Hydromorphone by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Hydromorphone by Application (2020-2031)
 Figure 57. Global Hydromorphone Price (US$/Unit) by Application (2020-2031)
 Figure 58. Hydromorphone Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart